首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1834005

全球生命科學軟體市場：機會與策略展望（至2034年）

Life Science Software Global Market Opportunities And Strategies 2034

出版日期: 2025年10月06日 | 出版商:

The Business Research Company | 英文 342 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2019 年全球生命科學軟體市場規模為 99.377 億美元，預計到 2024 年將以超過 12.00% 的年複合成長率(CAGR)成長。

生命科學軟體是指專為支援和最佳化生命科學領域（包括製藥、生物技術、醫療設備、醫療保健和臨床研究）的活動而設計的專用數位解決方案。這類軟體用於管理大量複雜的生物學、臨床和營運數據，幫助機構改善決策、簡化研究流程、確保合規性並改善患者預後。

生命科學軟體市場由營業單位（組織、獨資企業和夥伴關係）銷售的生命科學軟體所構成，這些軟體由研究人員、科學家、醫療保健提供者、製藥公司和監管機構用於藥物發現和開發過程中的各個環節，包括臨床試驗、監管申報、藥物安全檢測活動、供應鏈營運和行銷職能。

擴大臨床試驗和外包（CRO）

過去一段時間，臨床試驗和外包（CRO）的擴張推動了生命科學軟體市場的成長。臨床試驗的擴展以及對CRO（合約委外研發機構）依賴性的增強，正在推動對生命科學軟體的需求。這些活動需要先進的解決方案來進行試驗管理、數據分析和法規遵循，促使人們廣泛採用數位化工具來提高研究效率、準確性和擴充性。例如，根據英國製藥工業協會（ABPI）2023年11月發布的報告，2021年臨床試驗數量為394項，2022年增加至411項。此外，根據總部位於英國的生命科學網路研討會和虛擬活動提供者Xtalks 2023年5月發布的報告，截至2023年5月17日，ClinicalTrials.gov網站上已註冊的臨床試驗數量為452,604項。在這些已註冊的試驗中，有64,838項正在積極招募受試者，這意味著2021年註冊的試驗數量將增加365,000項。因此，臨床試驗和合約研究組織（CRO）業務的擴張正在推動生命科學軟體市場的成長。

利用下一代軟體推動生命科學領域的數位轉型

生命科學軟體市場的企業致力於打造下一代解決方案，以推動數位轉型、增強資料整合，並在整個製藥和生物技術價值鏈中實現精準創新。這些企業正利用尖端技術來滿足研發和臨床領域不斷變化的需求。例如，總部位於瑞士的顧問和技術精品公司TenSpin於2025年6月推出了TenSpin Solutions，這是一家專注於為生命科學產業開發創新尖端軟體解決方案的技術Start-Ups。這家新公司旨在透過提供以用戶為中心、數據驅動的系統來革新該行業，幫助製藥、生物技術、醫療技術和動物保健公司在不斷變化的數位化環境中進行適應和創新。 TenSpin Solutions專注於深厚的行業專長、卓越的技術能力和出色的用戶體驗，以支援成長和創新，並透過協同創新模式與生命科學公司緊密合作，精準客製化符合市場需求的解決方案。

全球生命科學軟體市場高度分散，眾多小型企業在其中營運，到 2024 年，前 10 大競爭對手將佔據 24.71% 的市場佔有率。

一般市場定義
概述
生命科學軟體市場定義與細分
按類型分類的市場細分
- 預測
- 說明型
- 處方類型
市場區隔：依部署方式
- 本地部署
- 主持人
市場區隔：按應用
- 行銷
- 遵守
- 研究與開發
- 藥物警戒
- SCM
市場區隔：依最終用戶分類
- 醫療機構
- 生物製藥業
- 醫療設備業
- 醫學研究中心

第7章：主要市場趨勢

利用新一代軟體推動生命科學領域的數位轉型
戰略生態系統與人工智慧主導平台加速生命科學領域的數位轉型
新一代人工智慧驅動的數位病理學解決方案，變革研究和診斷
策略合作透過先進的雲端解決方案變革生命科學領域的參與方式
人工智慧驅動的平台重新定義了藥物發現和開發。
用於簡化生物製藥計劃管理和商業化的下一代雲端平台

第8章：全球生命科學軟體成長分析及策略分析框架

全球生命科學軟體的 PESTEL 分析
- 政治
- 經濟
- 社會
- 科技
- 環境
- 法律
終端用戶產業（B2B）分析
- 醫療機構
- 生物製藥業
- 醫療設備業
- 醫學研究中心
- 其他最終用戶
全球生命科學軟體市場：成長率分析
市場成長表現（2019-2024）
- 市場促進因素（2019-2024）
- 市場限制（2019-2024）
市場成長預測（2024-2029年，2034年）
預期成長貢獻因素
- 數量成長的促成因素
- 促進要素
- 抑制因素
全球生命科學軟體：潛在市場規模 (TAM)

9. 全球生命科學軟體市場：細分

全球生命科學軟體市場按類型、效能和預測分類（2019-2024年、2029年、2034年）
全球生命科學軟體市場：依部署方式、效能與預測（2019-2024 年、2029 年、2034 年）
全球生命科學軟體市場：依應用、效能和預測分類（2019-2024年、2029年、2034年）
全球生命科學軟體市場（依最終用戶分類）：績效與預測（2019-2024年、2029年、2034年）
全球生命科學軟體市場：細分、預測（按類型）、效能和預測（2019-2024 年、2029 年、2034 年）
全球生命科學軟體市場：細分、說明（按類型）、效能和預測（2019-2024 年、2029 年、2034 年）
全球生命科學軟體市場：細分、預測（按類型）、績效及預測（2019-2024年、2029年、2034年）

第10章：生命科學軟體市場：區域與國家分析

全球生命科學軟體市場：區域表現與預測（2019-2024年、2029年、2034年）
全球生命科學軟體市場：國家、績效及預測（2019-2024 年、2029 年、2034 年）

第11章亞太市場

第12章西歐市場

第13章東歐市場

第14章北美市場

第15章：南美市場

第16章中東市場

第17章：非洲市場

第18章：競爭格局與公司概況

公司簡介
Veeva Systems Inc
IQVIA Holdings Inc
Microsoft Corporation（Life Sciences）
Oracle Corporation
Dassault Systemes SE（Medidata Solution Inc.）

第19章：其他領先和創新企業

SAP SE
UnitedHealth Group Incorporated（Optum Inc.）
Thermo Fisher Scientific Inc.
PerkinElmer
Certara
Cognizant Technology Solutions Corporation
Clario
PAREXEL International Corporation
DXC Technology Co
Persistent Systems
Veradigm（前身為Allscripts Healthcare LLC）
International Business Machines Corp.
Fujitsu Ltd.
ArisGlobal LLC
LabWare

第20章：競爭基準化分析

第21章競爭格局分析

第22章重大併購

Instem Acquires Rockstep Solutions To Enhance Digital Platforms For Preclinical Research
Siemens Expands Life Sciences R&D Capabilities With Dotmatics Acquisition
Valsoft Enters Life Sciences Sector With Acquisition Of Anju Software

第23章生命科學軟體的最新發展

新一代基於代理的人工智慧平台革新生命科學轉型
面向生命科學的模組化真實世界數據分析平台
新平台重新定義生命科學領域的品質和生產控制
人工智慧驅動的分析平台變革生命科學領域的資料整合

第24章：機會、策略與潛力分析

2029年全球生命科學軟體市場：蘊藏新機會的國家
2029年全球生命科學軟體市場：蘊藏新機會的細分市場
2029年全球生命科學軟體市場：成長策略
- 基於市場趨勢的策略
- 競爭對手策略

第25章：生命科學軟體市場：結論與建議

結論
建議
- 產品
- 分配
- 價格
- 促銷
- 人們

第26章附錄

簡介目錄

Product Code: o&s1800

Life science software refers to specialized digital solutions designed to support and optimize activities within the life sciences sector, encompassing pharmaceuticals, biotechnology, medical devices, healthcare and clinical research. This software is used to manage vast volumes of complex biological, clinical and operational data, enabling organizations to improve decision-making, streamline research, maintain compliance and enhance patient outcomes.

The life science software market consists of sales, by entities (organizations, sole traders, or partnerships), of life science software that are used by researchers, scientists, healthcare providers, pharmaceutical companies and regulatory bodies. It is employed throughout the drug discovery and development process, in clinical trials, regulatory submissions, pharmacovigilance activities, supply chain operations and marketing functions.

The global life science software market was valued at $9,937.70 million in 2019 which grew till 2024 at a compound annual growth rate (CAGR) of more than 12.00%.

Expansion Of Clinical Trials And Outsourcing (CROs)

Expansion of clinical trials and outsourcing (CROs) propelled the growth of the life science software market during the historic period. The growth of clinical trials and the rising reliance on contract research organizations (CROs) are fueling demand for life science software. These activities require advanced solutions for trial management, data analysis and regulatory compliance, driving wider adoption of digital tools to enhance efficiency, accuracy and scalability in research. For instance, in November 2023, according to a report published by the Association of the British Pharmaceutical Industry (ABPI), a UK-based association, there were 394 trials in 2021; the clinical trial number increased to 411 in 2022. Additionally, in May 2023, according to Xtalks, a Canada-based company specializing in providing life science webinars and virtual events, there are 452,604 clinical studies that have been registered on ClinicalTrials.gov as of May 17, 2023. 64,838 studies out of the total number that have been registered are actively seeking participants, which is an increase of 365,000 registered trials in 2021. Therefore, expansion of clinical trials and outsourcing (CROs) propelled the growth of the life science software market.

Driving Digital Transformation In Life Sciences Through Next-Generation Software

Companies operating in the life science software market are focusing on creating next-generation solutions that drive digital transformation, enhance data integration and enable precision innovation across the pharmaceutical and biotechnology value chain. These companies are leveraging advanced technologies to address evolving needs in research, development and clinical practices. For instance, in June 2025, Tenthpin, a Switzerland-based boutique consulting and technology company, launched Tenthpin Solutions as a technology start-up dedicated to developing innovative and cutting-edge software solutions for the Life Sciences industry. The new company aims to revolutionize the sector by providing user-centric, data-driven systems that help pharmaceutical, biotech, medical technology and animal health companies adapt and innovate in a transforming digital landscape. Tenthpin Solutions focuses on deep industry expertise, excellent technology skills and superior user experience to support growth and innovation, working closely with Life Sciences companies through co-innovation models to precisely tailor solutions to market needs.

The global life science software market is fairly fragmented, with a large number of small players operating in the market. The top ten competitors in the market made up to 24.71% of the total market in 2024.

Life Science Software Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global life science software market as it emerges from the COVID-19 shut down.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for life science software? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The life science software market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider life science software market; and compares it with other markets.

The report covers the following chapters

Introduction And Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type, by deployment, by application and by end user.
Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
Growth Analysis And Strategic Analysis Framework- Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
Global Market Size And Growth- Global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
Regional And Country Analysis- Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
Market Segmentation- Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by type, by robot type, by application and by industry in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
Regional Market Size And Growth- Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
Competitive Dashboard- Briefs on competitive dashboard of major players.
Key Mergers And Acquisitions- Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
Recent Developments- Information on recent developments in the market covered in the report.
Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
Conclusions And Recommendations- This section includes recommendations for life science software providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
Appendix This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report

Markets Covered:

1) By Type: Predictive; Descriptive; Prescriptive
2) By Deployment: On-Premises; Hosted
3) By Application: Marketing; Compliance; R&D; Pharmacovigilance; SCM
4) By End User: Healthcare Institutes; Biopharmaceutical Industry; Medical Devices Industry; Medical Research Centers
Companies Mentioned: Veeva Systems Inc.; IQVIA Holdings, Inc.; Microsoft (Life Sciences); Oracle Corp.; Dassault Systemes SE (Medidata Solution Inc.)
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time-series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; life science software indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

1 Executive Summary

1.1 Life Science Software - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

6.1 General Market Definition
6.2 Summary
6.3 Life Science Software Market Definition And Segmentations
6.4 Market Segmentation By Type
- 6.4.1 Predictive
- 6.4.2 Descriptive
- 6.4.3 Prescriptive
6.5 Market Segmentation By Deployment
- 6.5.1 On-Premises
- 6.5.2 Hosted
6.6 Market Segmentation By Application
- 6.6.1 Marketing
- 6.6.2 Compliance
- 6.6.3 R&D
- 6.6.4 Pharmacovigilance
- 6.6.5 SCM
6.7 Market Segmentation By End User
- 6.7.1 Healthcare Institutes
- 6.7.2 Biopharmaceutical Industry
- 6.7.3 Medical Devices Industry
- 6.7.4 Medical Research Centers

7 Major Market Trends

7.1 Driving Digital Transformation In Life Sciences Through Next-Generation Software
7.2 Strategic Ecosystems And AI-Driven Platforms Accelerate Digital Transformation In Life Sciences
7.3 Next-Generation AI-Powered Digital Pathology Solutions Transforming Research And Diagnostics
7.4 Strategic Collaboration To Transform Life Sciences Engagement Through Advanced Cloud Solutions
7.5 AI-Powered Platform Redefines Drug Discovery And Development
7.6 Next-Generation Cloud Platform To Streamline Biopharma Project Management And Commercialization

8 Global Life Science Software Growth Analysis And Strategic Analysis Framework

8.1 Global Life Science Software PESTEL Analysis
- 8.1.1 Political
- 8.1.2 Economic
- 8.1.3 Social
- 8.1.4 Technological
- 8.1.5 Environmental
- 8.1.6 Legal
8.2 Analysis Of End Use Industries (B2B)
- 8.2.1 Healthcare Institutes
- 8.2.2 Biopharmaceutical Industry
- 8.2.3 Medical Devices Industry
- 8.2.4 Medical Research Centers
- 8.2.5 Other End-User
8.3 Global Life Science Software Market Growth Rate Analysis
8.4 Historic Market Growth, 2019 - 2024, Value ($ Million)
- 8.4.1 Market Drivers 2019 - 2024
- 8.4.1 Market Restraints 2019- 2024
8.5 Forecast Market Growth, 2024 - 2029, 2034F Value ($ Million)
8.6 Forecast Growth Contributors/Factors
- 8.6.1 Quantitative Growth Contributors
- 8.6.2 Drivers
- 8.6.3 Restraints
8.7 Global Life Science Software Total Addressable Market (TAM)

9 Global Life Science Software Market Segmentation

9.1 Global Life Science Software Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.2 Global Life Science Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.3 Global Life Science Software Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.4 Global Life Science Software Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.5 Global Life Science Software Market, Sub-Segmentation Of Predictive, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.6 Global Life Science Software Market, Sub-Segmentation Of Descriptive, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.7 Global Life Science Software Market, Sub-Segmentation Of Prescriptive, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

10 Life Science Software Market, Regional and Country Analysis

10.1 Global Life Science Software Market, By Region, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
10.2 Global Life Science Software Market, By Country, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

11 Asia-Pacific Market

11.1 Summary
11.2 Market Overview
- 11.2.1 Region Information
- 11.2.2 Market Information
- 11.2.3 Background Information
- 11.2.4 Government Initiatives
- 11.2.5 Regulations
- 11.2.6 Regulatory Bodies
- 11.2.7 Major Associations
- 11.2.8 Taxes Levied
- 11.2.9 Corporate Tax Structure
- 11.2.10 Investments
- 11.2.11 Major Companies
11.3 Asia-Pacific Life Science Software Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.4 Asia-Pacific Life Science Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.5 Asia-Pacific Life Science Software Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.6 Asia-Pacific Life Science Software Market: Country Analysis
11.7 China Market
11.8 Summary
11.9 Market Overview
- 11.9.1 Country Information
- 11.9.2 Market Information
- 11.9.3 Background Information
- 11.9.4 Government Initiatives
- 11.9.5 Regulations
- 11.9.6 Regulatory Bodies
- 11.9.7 Major Associations
- 11.9.8 Taxes Levied
- 11.9.9 Corporate Tax Structure
- 11.9.10 Major Companies
11.10 China Life Science Software Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.11 China Life Science Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.12 China Life Science Software Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.13 India Market
11.14 India Life Science Software Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.15 India Life Science Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.16 India Life Science Software Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.17 Japan Market
11.18 Summary
11.19 Market Overview
- 11.19.1 Country Information
- 11.19.2 Market Information
- 11.19.3 Background Information
- 11.19.4 Government Initiatives
- 11.19.5 Regulations
- 11.19.6 Regulatory Bodies
- 11.19.7 Major Associations
- 11.19.8 Taxes Levied
- 11.19.9 Corporate Tax Structure
- 11.19.10 Investments
- 11.19.11 Major Companies
11.20 Japan Life Science Software Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.21 Japan Life Science Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.22 Japan Life Science Software Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.23 Australia Market
11.24 Australia Life Science Software Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.25 Australia Life Science Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.26 Australia Life Science Software Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.27 Indonesia Market
11.28 Indonesia Life Science Software Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.29 Indonesia Life Science Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.30 Indonesia Life Science Software Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.31 South Korea Market
11.32 Summary
11.33 Market Overview
- 11.33.1 Country Information
- 11.33.2 Market Information
- 11.33.3 Background Information
- 11.33.4 Government Initiatives
- 11.33.5 Regulations
- 11.33.6 Regulatory Bodies
- 11.33.7 Major Associations
- 11.33.8 Taxes Levied
- 11.33.9 Corporate Tax Structure
- 11.33.10 Investments
- 11.33.11 Major Companies
11.34 South Korea Life Science Software Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.35 South Korea Life Science Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.36 South Korea Life Science Software Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

12 Western Europe Market

12.1 Summary
12.2 Market Overview
- 12.2.1 Region Information
- 12.2.2 Market Information
- 12.2.3 Background Information
- 12.2.4 Government Initiatives
- 12.2.5 Regulations
- 12.2.6 Regulatory Bodies
- 12.2.7 Major Associations
- 12.2.8 Taxes Levied
- 12.2.9 Corporate Tax Structure
- 12.2.10 Investments
- 12.2.11 Major Companies
12.3 Western Europe Life Science Software Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.4 Western Europe Life Science Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.5 Western Europe Life Science Software Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.6 Western Europe Life Science Software Market: Country Analysis
12.7 UK Market
12.8 UK Life Science Software Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.9 UK Life Science Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.10 UK Life Science Software Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.11 Germany Market
12.12 Germany Life Science Software Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.13 Germany Life Science Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.14 Germany Life Science Software Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.15 France Market
12.16 France Life Science Software Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.17 France Life Science Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.18 France Life Science Software Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.19 Italy Market
12.20 Italy Life Science Software Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.21 Italy Life Science Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.22 Italy Life Science Software Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.23 Spain Market
12.24 Spain Life Science Software Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.25 Spain Life Science Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.26 Spain Life Science Software Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

13 Eastern Europe Market

13.1 Summary
13.2 Market Overview
- 13.2.1 Region Information
- 13.2.2 Market Information
- 13.2.3 Background Information
- 13.2.4 Government Initiatives
- 13.2.5 Regulations
- 13.2.6 Regulatory Bodies
- 13.2.7 Major Associations
- 13.2.8 Taxes Levied
- 13.2.9 Corporate Tax Structure
- 13.2.10 Major Companies
13.3 Eastern Europe Life Science Software Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.4 Eastern Europe Life Science Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.5 Eastern Europe Life Science Software Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.6 Eastern Europe Life Science Software Market: Country Analysis
13.7 Russia Market
13.8 Russia Life Science Software Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.9 Russia Life Science Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.10 Russia Life Science Software Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

14 North America Market

14.1 Summary
14.2 Market Overview
- 14.2.1 Region Information
- 14.2.2 Market Information
- 14.2.3 Background Information
- 14.2.4 Government Initiatives
- 14.2.5 Regulations
- 14.2.6 Regulatory Bodies
- 14.2.7 Major Associations
- 14.2.8 Taxes Levied
- 14.2.9 Corporate Tax Structure
- 14.2.10 Investments
- 14.2.11 Major Companies
14.3 North America Life Science Software Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.4 North America Life Science Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.5 North America Life Science Software Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.6 North America Life Science Software Market: Country Analysis
14.7 USA Market
14.8 Summary
14.9 Market Overview
- 14.9.1 Country Information
- 14.9.2 Market Information
- 14.9.3 Background Information
- 14.9.4 Government Initiatives
- 14.9.5 Regulations
- 14.9.6 Regulatory Bodies
- 14.9.7 Major Associations
- 14.9.8 Taxes Levied
- 14.9.9 Corporate Tax Structure
- 14.9.10 Investments
- 14.9.11 Major Companies
14.10 USA Life Science Software Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.11 USA Life Science Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.12 USA Life Science Software Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.13 Canada Market
14.14 Summary
14.15 Market Overview
- 14.15.1 Country Information
- 14.15.2 Market Information
- 14.15.3 Background Information
- 14.15.4 Government Initiatives
- 14.15.5 Regulations
- 14.15.6 Regulatory Bodies
- 14.15.7 Major Associations
- 14.15.8 Taxes Levied
- 14.15.9 Corporate Tax Structure
- 14.15.10 Investments
- 14.15.11 Major Companies
14.16 Canada Life Science Software Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.17 Canada Life Science Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.18 Canada Life Science Software Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

15 South America Market

15.1 Summary
15.2 Market Overview
- 15.2.1 Region Information
- 15.2.2 Market Information
- 15.2.3 Background Information
- 15.2.4 Government Initiatives
- 15.2.5 Regulations
- 15.2.6 Regulatory Bodies
- 15.2.7 Major Associations
- 15.2.8 Taxes Levied
- 15.2.9 Corporate Tax Structure
- 15.2.10 Major Companies
15.3 South America Life Science Software Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.4 South America Life Science Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.5 South America Life Science Software Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.6 South America Life Science Software Market: Country Analysis
15.7 Brazil Market
15.8 Brazil Life Science Software Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.9 Brazil Life Science Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.10 Brazil Life Science Software Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

16 Middle East Market

16.1 Summary
16.2 Market Overview
- 16.2.1 Region Information
- 16.2.2 Market Information
- 16.2.3 Background Information
- 16.2.4 Government Initiatives
- 16.2.5 Regulations
- 16.2.6 Regulatory Bodies
- 16.2.7 Major Associations
- 16.2.8 Taxes Levied
- 16.2.9 Corporate Tax Structure
- 16.2.10 Major Companies
16.3 Middle East Life Science Software Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16.4 Middle East Life Science Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16.5 Middle East Life Science Software Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

17 Africa Market

17.1 Summary
17.2 Market Overview
- 17.2.1 Region Information
- 17.2.2 Market Information
- 17.2.3 Background Information
- 17.2.4 Government Initiatives
- 17.2.5 Regulations
- 17.2.6 Regulatory Bodies
- 17.2.7 Major Associations
- 17.2.8 Taxes Levied
- 17.2.9 Corporate Tax Structure
- 17.2.10 Investments
- 17.2.11 Major Companies
17.3 Africa Life Science Software Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
17.4 Africa Life Science Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
17.5 Africa Life Science Software Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

18 Competitive Landscape And Company Profiles

18.1 Company Profiles
18.2 Veeva Systems Inc
- 18.2.1 Company Overview
- 18.2.2 Products And Services
- 18.2.3 Business Strategy
- 18.2.4 Financial Overview
18.3 IQVIA Holdings Inc
- 18.3.1 Company Overview
- 18.3.2 Products And Services
- 18.3.3 Business Strategy
- 18.3.4 Financial Overview
18.4 Microsoft Corporation (Life Sciences)
- 18.4.1 Company Overview
- 18.4.2 Products And Services
- 18.4.3 Business Strategy
- 18.4.4 Financial Overview
18.5 Oracle Corporation
- 18.5.1 Company Overview
- 18.5.2 Products And Services
- 18.5.3 Business Strategy
- 18.5.4 Financial Overview
18.6 Dassault Systemes SE (Medidata Solution Inc.)
- 18.6.1 Company Overview
- 18.6.2 Products And Services
- 18.6.3 Business Strategy
- 18.6.4 Financial Overview

19 Other Major And Innovative Companies

19.1 SAP SE
- 19.1.1 Company Overview
- 19.1.2 Products And Services
19.2 UnitedHealth Group Incorporated (Optum Inc.)
- 19.2.1 Company Overview
- 19.2.2 Products And Services
19.3 Thermo Fisher Scientific Inc.
- 19.3.1 Company Overview
- 19.3.2 Products And Services
19.4 PerkinElmer
- 19.4.1 Company Overview
- 19.4.2 Products And Services
19.5 Certara
- 19.5.1 Company Overview
- 19.5.2 Products And Services
19.6 Cognizant Technology Solutions Corporation
- 19.6.1 Company Overview
- 19.6.2 Products And Services
19.7 Clario
- 19.7.1 Company Overview
- 19.7.2 Products And Services
19.8 PAREXEL International Corporation
- 19.8.1 Company Overview
- 19.8.2 Products And Services
19.9 DXC Technology Co
- 19.9.1 Company Overview
- 19.9.2 Products And Services
19.10 Persistent Systems
- 19.10.1 Company Overview
- 19.10.2 Products And Services
19.11 Veradigm (formerly Allscripts Healthcare LLC)
- 19.11.1 Company Overview
- 19.11.2 Products And Services
19.12 International Business Machines Corp.
- 19.12.1 Company Overview
- 19.12.2 Products And Services
19.13 Fujitsu Ltd.
- 19.13.1 Company Overview
- 19.13.2 Products And Services
19.14 ArisGlobal LLC
- 19.14.1 Company Overview
- 19.14.2 Products And Services
19.15 LabWare
- 19.15.1 Company Overview
- 19.15.2 Products And Services

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

22.1 Instem Acquires Rockstep Solutions To Enhance Digital Platforms For Preclinical Research
22.2 Siemens Expands Life Sciences R&D Capabilities With Dotmatics Acquisition
22.3 Valsoft Enters Life Sciences Sector With Acquisition Of Anju Software

23 Recent Developments In Life Science Software

23.1 Next-Generation Agentic AI Platform Revolutionizes Life Sciences Transformation
23.2 A Modular Real-World Data Analytics Platform For Life Sciences
23.3 New Platform Redefines Quality And Manufacturing Management In Life Sciences
23.4 AI-Powered Analytics Platform Transforms Data Integration In Life Sciences

24 Opportunities And Strategies and Potential Analysis

24.1 Global Life Science Software Market In 2029 - Countries Offering Most New Opportunities
24.2 Global Life Science Software Market In 2029 - Segments Offering Most New Opportunities
24.3 Global Life Science Software Market In 2029 - Growth Strategies
- 24.3.1 Market Trend Based Strategies
- 24.3.2 Competitor Strategies